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Abstract 
Background: Anterior cervical 
decompression and fusion (ACDF) is a 
common procedure in neurosurgical 
practice to manage the cervical cord/nerve 
roots compression by intervertebral disk 
herniation / osteophytic formation. 
However, cervical total disk replacement 
(TDR) progressively became a feasible 
alternative to ACDF in surgical practice. 
This procedure is thought to have many 
advantages compared to classical ACDF. 
The aim of the present study is to 
investigate if TDR is superior as outcome 
measures than ACDF, by reviewing the 
published data available to date. 
Methods: We searched several electronic 
databases up to December 2010. Outcomes 
sought includes pain relief, functional 
capacity, quality of life, adjacent disk 
disease, secondary surgeries, 
kinematics/range of motion, return to work, 
adverse events, potential candidacy rate for 
surgery. We selected mainly randomized 
controlled trials. 
Results: Compared to ACDF, TDR has 
superior or equal clinical outcomes, a lower 
incidence of adjacent disc disease 
(radiological +/- clinical), lower rate of 
secondary revision surgeries, supplemental 
fixation or adjacent segment reoperation, 
superior spine kinematics, which is 
maintained over time, earlier return to 
work. On the other hand, the presented 
studies have shown that TDR exposes the 
patients to more frequent postoperative 
events and have an inferior candidacy rate 
compared to ACDF. We did not have access 
to straight –forward economic data, but 
TDR seems to be more costly than ACDF. 
Conclusions: TDR already represents a 
well-established technique in the 
armamentarium to manage the cervical disc 
herniation, a method required to be 
handled by any surgeon involved in spinal 
care. 
Keywords: cervical arthroplasy, cervical 
total disc replacement, Bryan, Prestige, Pro-
Disc-C, ACDF 
Background 
Although anterior cervical discectomy 
and fusion (ACDF) is the regular 
management for degenerative cervical disc 
disease, concerns regarding adjacent level 
degeneration and loss of motion have 
suggested that arthroplasty may be a better 
alternative. This procedure, which occurred 
quite recently in the armamentarium of 
therapies in spine surgery, became 
increasingly interesting for the medical 
community involved in spinal care. Table 1 
figures the rationale of using cervical TDR 
over classical ACDF.  
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TABLE 1 
Rationale for cervical total disc 
replacement – comparison with ACDF 
Measurement ACDF Cervical Total Disc 
Replacement (TDR)
Spinal segmental 
motion 
Absent Normal 
Incidence of 
adjacent segment 
disease 
Increased Decreased 
Intraoperative morbidity 
Supplemental 
instrumentation 
Anterior 
cervical 
plate 
None 
Exposure Equal Equal 
Operative time Equal Equal ( after learning 
curve) 
Postoperative morbidity 
External 
immobilization 
Rigid 
cervical 
collar 
None 
Return to normal 
activity 
At least one 
month 
As early as 1-2 wks 
Pseudarthrosis Increased Absent 
Instrumentation 
failure 
Minimal Minimal 
 
Cervical arthroplasy – historical timelines 
1934 - Mixter and Barr described 
operations for the removal of the ruptured 
intervertebral disc (lumbar) 
1943 - Semmes and Murphey published 
their landmark paper, “The Syndrome of 
Unilateral Rupture of the Sixth Cervical 
Intervertebral Disc.” 
1955 - In 1955, Robinson and Smith 
briefly described anterior discectomies and 
interbody arthrodesis for cervical disc 
Jan 1964 - The first report of a cervical 
disc replacement - South African Medical 
Journal  
1966 - Fernstorm tried a method by 
placing a stainless steel ball into lumber and 
cervical disc center 
1989 - Cummins-Bristol Disc 
1990 - Bryan cervical disc 
1991 – Clinical trial initiated to 
investigate Cummins-Bristol Disc 
2002 – Pilot study to investigate 
Frenchay/Prestige cervical disc 
2002 – Results of Bryan cervical disc 
clinical trial were published 
2007 – FDA approval for Prestige Disc 
(Medtronic, Inc.) 
2007 – FDA approval for ProDisc-C 
device (Synthes, Inc.) 
2009 – FDA approval for Bryan cervical 
disc (Medtronic, Inc.)  
FDA aproved devices 
At the moment, there are three FDA 
approved devices for cervical disc 
arthroplasty: Prestige  ST (Medtronic), 
Pro-Disc-C (Synthes) and Bryan 
(Medtronic) (See Table 1). However, an 
increasing number of devices with this 
purpose are in various stages of Institutional 
Devices Evaluation (IDE)  for  FDA 
approval: PRESTIGE LP Cervical Disc 
(Medtronic); CerviCore (Stryker Spine); 
PCM (NuVasive, Inc); Advent™ Cervical 
Disc (Orthofix International N.V.); Activ C 
disc prosthesis (B. Braun/Aesculap Spine); 
NeoDisc (NuVasive, Inc); DISCOVER™ 
Artificial Cervical Disc (DePuy Spine, 
Inc.); Mobi-C (LDR Spine USA); 
SECURE®-C Cervical Artificial Disc 
(Globus Medical Inc); Kineflex-C 
(SpinalMotion). ClinicalTrials.gov reports 
19 on-going IDE trials concerning cervical 
disc prosthesis 
The Prestige ST cervical disc is a metal 
on metal device. It is made of stainless steel 
and contains two components- a ball and a 
trough that articulate. It is attached to the 
cervical vertebrae with screws. It is 
manufactured from titanium ceramic 
composite material. A porous titanium 
plasma spray coating on the end plate 
surface facilitates bone in growth and long 
term fixation. 
The Pro-Disc –C cervical disc is a metal 
on polymer device. It has cobalt-chromium 
end plates with a central keel for anchorage 
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to the vertebral bodies and a locking core of 
ultra high molecular weight polyethylene 
(UHMWPE) as a central polymer that 
provides a ball and socket articulation. In 
order to be compatible with tissue, the 
endplates are coated a titanium plasmapore. 
The Bryan cervical disc is also a metal on 
polymer device. It is a single piece of a 
porous coated, clamshell shaped titanium 
endplates with a polycarbonate, 
polyurethane core. 
 
 
Figure 1  The Prodisc C device. The prosthesis A 
inserted on a patient at C4/C5 level – lateral view B 
 
 
Figure 2 The Bryan device.  The prosthesis A 
inserted in vitro B and on a patient at C6/C7 level – 
lateral view C 
 
Figure 3 The Prestige device. The prosthesis A 
inserted in vitro B and on a patient at C5/C6 level – 
lateral view C, flexion D, extension E 
Methods 
We performed a literature review in the 
following databases: The Cochrane Library 
and Medline (National Library of 
Medicine). The review was limited to 
studies published between 2000 and 2010. 
The used keywords were: “cervical 
arthroplasty”, “cervical prosthesis”, 
“ProDisc C”, “Bryan”, and “Prestige”.  The 
search plan and the selection and quality 
ranking of the pertinent studies were 
carried out and analyzed separately by two 
persons in a first step and jointly 
synthesized and discussed in a second step. 
The studies that had been found were 
selected according to the quality criteria of 
the Jadad Score (2000) for randomized 
controlled trials (7, 8) and the checklist of 
Downs and Black (1998) for randomized 
and nonrandomized studies. Only 
randomized controlled trials, comparing 
ACDF vs cervical arthroplasty were 
included. 17 studies were identified.  
We tracked information about the 
following parameters: clinical outcome, 
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adjacent disc disease, kinematics, secondary 
surgeries, return to work, adverse events. 
Clinical outcome: TDR superior to ACDF  
Some studies reported superior results 
TDR vs ACDF in terms of clinical 
outcome. Garrido BJ et al. investigated 47 
patients randomly managed by ACDF and 
TDR. At 48 months follow-up they found 
improved functional outcomes for NDI 
(Neck Disability Index), neck/arm pain 
VAS scores, and the SF-36 physical/mental 
health component scores for both the 
Bryan arthroplasty and ACDF cohorts. 
There has been no degradation of 
functional outcomes from 24 to 48 months 
for NDI, VAS of neck and arm, and SF-36 
(5). They found superior results for cervical 
arthroplasty group. Heller JG et al. studied 
563 patients (242 TDR vs 221 single-level 
ACDF). At 24 months follow-up the 
investigational group patients treated with 
the artificial disc had a statistically greater 
improvement in the primary outcome 
variables: NDI  score (P = 0.025) and 
overall success (P = 0.010) compared to 
ACDF group (6). In another study, Riina J 
et al. operated 19 patients randomly using 
TDR and ACDF and follow them for 24 
months. Patients who underwent 
arthroplasty demonstrated greater 
improvement in neurologic function and 
neck pain than patients who underwent 
cervical discectomy and fusion (15). Finally, 
Sasso RC et al. managed 115 patients 
randomized in a 1:1 ratio to ACDF  or 
TDR. At 24 months follow up, the 
investigational group had statistically 
significant (P<0.05) improvements as 
assessed by the Neck Disability Index, the 
Neck Pain Score, and SF-36 Physical 
component scores. The improvement in 
the Mental Component Subscore values for 
the BRYAN and control groups was 
equivalent at 24 months (P=0.055). Arm 
pain relief was similar in both groups 
(P=0.152) (17, 18).  
Clinical outcome: no differences TDR vs 
ACDF  
On the other hand, there are studies 
showing no differences in clinical outcome 
post ACDF vs TDR. Bhadra AK et al. 
studied 60 patients: (15 TDR, 15 plate and 
tricortical autograft, 15 plate, cage, and bone 
substitute, 15  cage only) at 31 months 
follow up. The clinical outcome in terms of 
VAS of neck and arm pain and SF12 
physical and mental score improvement 
(P=0.001) were comparable in all four 
techniques (3). In another study, 
Buchowski JM et al.  analyzed 199 patients: 
106 patients (53%) TDR vs 93 (47%) 
ACDF at 24 months follow up (4). Patients 
in both the arthroplasty and arthrodesis 
groups had improvement following 
surgery; furthermore, improvement was 
similar between the groups, with no 
worsening of myelopathy in the 
arthroplasty group. Kim SW et al. had 105 
patients with 63 TDR placed in 51 patients 
and 54 patients operated with ACDF, 26 
single level , 28 double level at 19 months 
follow up (9). There was clinical 
improvement within each group in terms of 
VAS and NDI scores from pre-op to final 
follow-up, but not significantly between the 
two groups for both single (VAS p=0.8371, 
NDI p=0.2872) and double (VAS 
p=0.2938, NDI p=0.6753) level surgeries. 
Murrey D et al. operated 209 patients (106 
ACDF; 103 TDR) and follow them for 24 
months (13). NDI and SF-36 scores, VAS 
neck pain intensity and frequency as well as 
VAS arm pain intensity and frequency  were 
significantly less compared with pre-
surgery scores at all follow-up visits for 
both the treatment groups (p<.0001). 
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Neurologic success (improvement or 
maintenance) was achieved at 24 months in 
90.9% of ProDisc-C and 88.0% of fusion 
patients (p=.638). However, at 24 months, 
there was a statistically significant difference 
in medication usage with 89.9% of 
ProDisc-C patients not on strong narcotics 
or muscle relaxants, compared with 81.5% 
of ACDF patients. 49 patients were 
randomly managed by Nabhan A et al. with 
ACDF or TDR (14). At 36 months follow-
up, after both procedures, a significant pain 
reduction in neck and arm was observed, 
without significant differences between 
both groups.  
Adjacent disc disease 
One major advantage claimed for TDR 
is the absence of adjacent disc disease. This 
condition occurs following ACDF, due to 
the additional mechanical stress over the 
discs adjacent to the ACDF site. Two 
reports investigated the adjacent disc disease 
occurrence in TDR vs ACDF. Kim SW et 
al. studied 105 patients. 63 TDR were 
placed in 51 patients.  A single level 
procedure was performed in 39 patients and 
a two-level procedure in the other 12 (9). 
Fifty-four patients underwent ACDF, 26 
single level cases and 28 double level cases. 
Mean follow-up was 19 months. 
Statistically significant (p<0.0001 and 
p=0.0172) differences in the trend of 
intervertebral height measurements 
between the two groups were noted at all 
levels except for the anterior intervertebral 
height  of single level surgeries at the upper 
(p=0.1264) and lower (p=0.7598) adjacent 
levels as well as posterior intervertebral 
height for double level surgeries at the 
upper (p=0.8363) adjacent level. 
Radiological change was 3.5 times more 
observed for the ACDF group. In another 
study the patients were treated with the 
Affinity Anterior Cervical Cage System 
(158) or the Bryan Artificial Cervical Disc 
(74) (16). Follow-up period was 24 months. 
Fusion was associated with a significant 
increase in x-ray film-based changes of 
adjacent-disc disease (p = 0.009, odds ratio 
[OR] 2.44). In the cage fusion series, the 
incidence of symptomatic adjacent-level 
DDD was statistically greater than that in 
the group treated with the artificial disc (p 
= 0.018). 
Secondary surgeries  
We also investigated the rates of 
secondary surgeries needed to fix 
complications such as: adjacent disc disease 
or pseudarthrosis.  Garrido BJ et al. studied 
47 patients randomly managed with ACDF 
or cervical arthroplasy, at a follow up of 48 
months. 6 additional surgeries were needed 
in ACDF group (3 adjacent level, 1- remote 
level and 2 for pseudarthrosis) and one 
surgery in TDR group for adjacent level 
(5). Heller JG et al. investigated 563 
patients (242 TDR vs  221 single-level 
ACDF) and follow them for 2 years.  There 
was no statistical difference between the 2 
groups with regard to the rate of secondary 
surgical procedures performed subsequent 
to the index procedure (6). In another study 
(13), two hundred nine patients were 
randomized and treated (106 ACDF; 103 
ProDisc-C).  Patients were assessed pre- 
and postoperatively at six weeks, 3, 6, 12, 
18, and 24 months. There was a statistically 
significant difference in the number of 
secondary surgeries with 8.5% of fusion 
patients needing a re-operation, revision, or 
supplemental fixation within the 24 month 
postoperative period compared with 1.8% 
of ProDisc-C patients (p=.033). Finally, in 
Mummaneni et al. study five hundred 
forty-one patients with single-level cervical 
DDD and radiculopathy were enrolled at 
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32 sites and randomly assigned to one of 
two treatment groups: 276 patients in the 
investigational group underwent anterior 
cervical discectomy and decompression and 
arthroplasty with the PRESTIGE ST 
Cervical Disc System (Medtronic Sofamor 
Danek); 265 patients in the control group 
underwent decompressive ACDF. Eighty 
percent of the arthroplasty-treated patients 
(223 of 276) and 75% of the control patients 
(198 of 265) completed clinical and 
radiographic follow-up examinations at 
routine intervals for 2 years after surgery. 
The arthroplasty group had a statistically 
significant lower rate of secondary revision 
surgeries (p = 0.0277) and supplemental 
fixation (p = 0.0031). Rate of adjacent-
segment reoperation was significantly lower 
in the investigational group as well (p = 
0.0492, log-rank test) (11, 12). 
Kinematics / range of motion 
One advantage of TDR vs ACDF seems 
to be a better kinematics, with larger range 
of motion by keeping the operated vertebral 
segment mobil. The following studies were 
published in this regard. Kim SW et al. 
studied 105 patients. 63 TDR were inserted 
in 51 patients. A single level ACDF 
procedure was performed in 39 patients and 
a two-level procedure in the other 12. 54 
patients underwent ACDF, 26 single level 
cases and 28 double level cases. Mean 
follow up period was 19 months. Overall, 
ROM and intervertebral height was 
relatively well maintained during the 
follow-up in the Bryan group compared to 
ACDF. Regardless of the number of levels 
operated on, significant differences were 
noted for overall ROM of the cervical spine 
(p<0.0001) and all other levels except at the 
upper adjacent level for single level 
surgeries (p=0.2872). Statistically 
significant (p<0.0001 and p=0.0172) 
differences in the trend of intervertebral 
height measurements between the two 
groups were noted at all levels except for 
the AIH of single level surgeries at the 
upper (p=0.1264) and lower (p=0.7598) 
adjacent levels as well as PIH for double 
level surgeries at the upper (p=0.8363) 
adjacent level (9). Radiological change was 
3.5 times more observed for the ACDF 
group. Sasso RC et al. treated  463 patients 
(221 ACDF  and 242 TDR). The  follow up 
was at  24 months. Significantly more 
motion was retained in the disc 
replacement group than the plated group at 
the index level (Sasso & Best, 2008; Sasso et 
al., 2008. The disc replacement group 
retained an average of 7.95 degrees at 24 
months. The preoperative motion was 6.43 
degrees and there was no evidence of 
degradation of motion over 24 months. In 
contrast, the average range of motion in the 
fusion group was 1.11 degrees at 3-month 
follow-up and gradually decreased to 0.87 
degrees at 24 months. The preoperative 
motion was 8.39 degrees. Murrey D et al., 
managed 209 patients (106 ACDF vs 103 
TDR). Results show that at 24 months 
postoperatively, 84.4% of ProDisc-C 
patients achieved a more than or equal to 4 
degrees of motion or maintained motion 
relative to preoperative baseline at the 
operated level (13). Nabhan A et al. studied  
49 pts 1:1 randomized TDR vs ACDF  at a 
follow up of 36 months. The range of 
motion of the treated segment with 
prosthesis remained unchanged 3 years 
after surgery in comparison to the 1-year 
result (14). The prosthesis shows a 
significant segmental motion in contrast to 
the fusion group at each RSA examination 
time (p < 0.05). Finally, Mummaneni PV 
et al. investigated 541 patients (276 TDR vs 
265 ACDF) (11, 12). At 24 months the 
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cervical disc implant maintained segmental 
sagittal angular motion averaging more than 
7 degrees. In the investigational group, 
there were no cases of implant failure or 
migration. 
Return to work  
One important issue to be taken into 
account is the professional outcome of this 
kind of patient following to TDR or 
ACDF. We found three studies reporting 
this kind of data. Heller JG et al. used 
Bryan devices (6). 563 patients were 
enrolled (242 TDR vs  221 single-level 
ACDF). They have data at 24 months 
follow-up. Patients who received the 
artificial cervical disc returned to work 
nearly 2 weeks earlier than the fusion 
patients (P = 0.015). Steinmetz MP  et 
al.,(19) used Prestige ST and Bryan devices. 
They studied 1004 patients and follow them 
for 24 months. At 6 weeks and 3 months, 
significantly more patients in the 
arthroplasty group were working compared 
with the fusion group. At 6 months and 
later, there was no significant difference in 
return-to-work rates. Overall, patients 
returned to work at a median of 101 days 
after arthroplasty, compared with 222 days 
after ACDF. Mummaneni PV et al. 
analyzed 541 pts. - 276 pts TDR (Prestige 
ST) vs 265 ACDF(11, 12). The patients in 
the investigational group returned to work 
16 days sooner than those in the control 
group.  
Adverse events/ dysphagia  
Two studies analyzed the adverse effects 
related to the cervical disk surgery, either by 
using ACDF or TDR. McAfee PC et al., 
2010 (10) used porous-coated motion 
(PCM) device in 151 patients and 
compared them with a control group of 100 
ACDF patients. The patients were followed 
for 12 months. The incidence of 
postoperative dysphagia and the long-term 
resolution of the dysphagia was greatly 
improved in the PCM group compared 
with the instrumented ACDF control 
group. Anderson PA et al., 2008 (1) 
reported four hundred sixty-three (463) 
patients having cervical radiculopathy and 
or myelopathy at a single level which were 
treated at 31 sites. A total of 242 patients 
received the disc and 221 patients had 
anterior cervical discectomy and fusion. All 
patients were evaluated before surgery and 
at 1.5, 3, 6, 12, and 24 months after surgery 
. No differences in overall medical events 
occurred between groups. Surgically related 
events occurred more frequently in the 
investigational group secondary to more 
complaints of postoperative dysphagia and 
late medical events occurred more 
frequently in the investigational patients. 
However, the more severe World Health 
Organization Grade 3 and 4 events 
occurred more frequently in the arthrodesis 
patients related to treatment of 
pseudarthrosis and persistent symptoms. 
Significantly, more cervical spine 
reoperations occurred in the fusion group. 
Only one spinal cord injury occurred and it 
was in the arthrodesis group and no patients 
had deep infection or death related to either 
procedure. 
Potential candidacy rate for cervical TDR 
Auerbach JD et al , 2008 (2) reviewed 
167 consecutive patients who underwent 
cervical spine surgery. The authors used the 
published contraindications and indications 
listed in trials of four different cervical disc 
arthroplasty devices: ProDisc-C (Synthes 
Spine, West Chester, PA), PRESTIGE LP 
(Medtronik Sofamor Danek, Memphis, 
TN), Bryan Cervical Disc prosthesis 
(Medtronik Sofamor Danek, Memphis, 
TN), and Porous Coated Motion (PCM; 
 
 
 
Romanian Neurosurgery (2011) XVIII 4: 456 - 464          463 
 
 
 
Cervitech, Rockaway, NJ). Of the 167 
patients (mean age 50.8 years, range 20-89 
years) reviewed, 91.6% (153/167) had 
fusion surgery and 8.4% (14/167) had non-
fusion surgery.  57 % percent (95/167) had 
absolute contraindications to cervical TDR, 
and within this group the average number 
of contraindications was 2.1 (SD=1.2, 
range 0-5). 43% (72/167) met the strict 
inclusion criteria, and had no exclusion 
criteria. If the indications were expanded to 
include treatment for adjacent segment 
disease (ASD), an additional 4.2% (7/167) 
of the patients would have qualified as 
candidates for cervical TDR. This study is 
very interesting, highlighting the fact that 
ACDF covers as surgical solution a larger 
group of patients than TDR. 
Conclusions 
Summarizing,  compared to ACDF, 
TDR has superior or equal clinical 
outcomes, a lower incidence of adjacent 
disc disease (radiological +/- clinical), 
lower rate of secondary revision surgeries, 
supplemental fixation or adjacent segment 
reoperation, superior spine kinematics, 
which is maintained over time, earlier 
return to work. On the other hand, the 
presented studies have shown that TDR 
exposes the patients to more frequent 
postoperative events and have an inferior 
candidacy rate compared to ACDF. We did 
not have access to straight –forward 
economic data, but TDR seems to be more 
costly than ACDF. Our final conclusion is 
that TDR already represents a well-
established technique in the 
armamentarium to manage the cervical disc 
herniation, a method required to be 
handled by any surgeon involved in spinal 
care. 
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TDR – total disc replacement;  
ACDF – anterior cervical decompression 
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